Retatrutide has emerged as a new medication in the fight against obesity. This revolutionary drug, categorized as a dual GLP-1 and GIP receptor agonist, exhibits promising results in clinical trials. By boosting https://keiransene374083.mybjjblog.com/tirzepatide-a-promising-new-treatment-for-obesity-48677326